Cargando…
Botulinum toxin and benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a clinical condition where lower urinary tract symptoms are caused by both a physically obstructing prostate as well as tight smooth muscles around the bladder outlet. Treatment of this condition with botulinum toxin has been used since 2003, but this interest h...
Autor principal: | Ng, Lay Guat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780293/ https://www.ncbi.nlm.nih.gov/pubmed/29379734 http://dx.doi.org/10.1016/j.ajur.2017.11.003 |
Ejemplares similares
-
Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009) -
Intraprostatic Botulinum Toxin injection in patients
with benign prostatic enlargement
por: Ilie, CP, et al.
Publicado: (2009) -
Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
por: Hsu, Yu-Chao, et al.
Publicado: (2016) -
Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
por: Chiang, Bing-Juin, et al.
Publicado: (2019) -
Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its’ effectiveness with botulinum toxin injection
por: Ergün, Osman, et al.
Publicado: (2017)